Growth Metrics

Eli Lilly (LLY) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $24.5 billion.

  • Eli Lilly's Retained Earnings rose 8065.71% to $24.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $24.5 billion, marking a year-over-year increase of 8065.71%. This contributed to the annual value of $24.5 billion for FY2025, which is 8065.71% up from last year.
  • Eli Lilly's Retained Earnings amounted to $24.5 billion in Q4 2025, which was up 8065.71% from $22.3 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Retained Earnings registered a high of $24.5 billion during Q4 2025, and its lowest value of $8.5 billion during Q2 2021.
  • For the 5-year period, Eli Lilly's Retained Earnings averaged around $12.4 billion, with its median value being $10.3 billion (2023).
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 23333.48% in 2021, then skyrocketed by 30.36% in 2022.
  • Eli Lilly's Retained Earnings (Quarter) stood at $9.0 billion in 2021, then rose by 12.1% to $10.0 billion in 2022, then increased by 2.69% to $10.3 billion in 2023, then soared by 31.35% to $13.5 billion in 2024, then skyrocketed by 80.66% to $24.5 billion in 2025.
  • Its Retained Earnings stands at $24.5 billion for Q4 2025, versus $22.3 billion for Q3 2025 and $17.4 billion for Q2 2025.